Skip to main content
SpringerLink
Log in

Heart failure with preserved ejection fraction

  • Invited Review
  • Published:
Pflügers Archiv - European Journal of Physiology Aims and scope Submit manuscript

Abstract

As part of this series devoted to heart failure (HF), we review the epidemiology, diagnosis, pathophysiology, and treatment of HF with preserved ejection fraction (HFpEF). Gaps in knowledge and needed future research are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

References

  1. Abudiab MM, Redfield MM, Melenovsky V, Olson TP, Kass DA, Johnson BD, Borlaug BA (2013) Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction. Eur J Heart Fail 15:776–785

    PubMed  Google Scholar 

  2. Ahmed A, Rich MW, Fleg JL, Zile MR, Young JB, Kitzman DW, Love TE, Aronow WS, Adams KFJ, Gheorghiade M (2006) Effects of digoxin on morbidity and mortality in diastolic heart failure: the Ancillary Digitalis Investigation Group trial. Circulation 114:397–403

    CAS  PubMed Central  PubMed  Google Scholar 

  3. Andersen MJ, Ersboll M, Axelsson A, Gustafsson F, Hassager C, Kober L, Borlaug BA, Boesgaard S, Skovgaard LT, Moller JE (2013) Sildenafil and diastolic dysfunction after acute myocardial infarction in patients with preserved ejection fraction: the Sildenafil and Diastolic Dysfunction After Acute Myocardial Infarction (SIDAMI) trial. Circulation 127:1200–1208

    CAS  PubMed  Google Scholar 

  4. Aronow WS, Ahn C, Kronzon I (1997) Effect of propranolol versus no propranolol on total mortality plus nonfatal myocardial infarction in older patients with prior myocardial infarction, congestive heart failure, and left ventricular ejection fraction > or =40 % treated with diuretics plus angiotensin-converting enzyme inhibitors. Am J Cardiol 80:207–209

    CAS  PubMed  Google Scholar 

  5. Ather S, Chan W, Bozkurt B, Aguilar D, Ramasubbu K, Zachariah AA, Wehrens XH, Deswal A (2012) Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. J Am Coll Cardiol 59:998–1005

    PubMed  Google Scholar 

  6. Bhatia RS, Tu JV, Lee DS, Austin PC, Fang J, Haouzi A, Gong Y, Liu PP (2006) Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 355:260–269

    CAS  PubMed  Google Scholar 

  7. Bishu K, Hamdani N, Kruger M, Mohammed SF, Ohtani T, Abdalrhim A, Ogut O, Burnett JC, Linke WA, Redfield MM (2010) cGMP enhancing therapy improves LV diastolic distensibility by phosphorylating titin. Circulation 122:A8754

    Google Scholar 

  8. Boilson BA, Schirger JA, Borlaug BA (2010) Caveat medicus! Pulmonary hypertension in the elderly: a word of caution. Eur J Heart Fail 12:89–93

    PubMed  Google Scholar 

  9. Borbély A, van der Velden J, PAPP Z, Bronzwaer JG, Edes I, Stienen GJ, Paulus WJ (2005) Cardiomyocyte stiffness in diastolic heart failure. Circulation 111:774–781

    PubMed  Google Scholar 

  10. Borbély A, Falcao-Pires I, van Heerebeek L et al (2009) Hypophosphorylation of the Stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium. Circ Res 104:780–786

    PubMed  Google Scholar 

  11. Borlaug BA, Kass DA (2008) Ventricular–vascular interaction in heart failure. Heart Fail Clin 4:23–36

    PubMed Central  PubMed  Google Scholar 

  12. Borlaug BA, Paulus WJ (2011) Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. Eur Heart J 32:670–679

    PubMed Central  PubMed  Google Scholar 

  13. Borlaug BA, Redfield MM (2011) Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum. Circulation 123:2006–2014

    PubMed Central  PubMed  Google Scholar 

  14. Borlaug BA, Jaber WA, Ommen SR, Lam CS, Redfield MM, Nishimura RA (2011) Diastolic relaxation and compliance reserve during dynamic exercise in heart failure with preserved ejection fraction. Heart 97:964–969

    PubMed Central  PubMed  Google Scholar 

  15. Borlaug BA, Lam CS, Roger VL, Rodeheffer RJ, Redfield MM (2009) Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction. J Am Coll Cardiol 54:410–418

    PubMed Central  PubMed  Google Scholar 

  16. Borlaug BA, Melenovsky V, Russell SD, Kessler K, Pacak K, Becker LC, Kass DA (2006) Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction. Circulation 114:2138–2147

    PubMed  Google Scholar 

  17. Borlaug BA, Nishimura RA, Sorajja P, Lam CS, Redfield MM (2010) Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction. Circ Heart Fail 3:588–595

    PubMed Central  PubMed  Google Scholar 

  18. Borlaug BA, Olson TP, Lam CS, Flood KS, Lerman A, Johnson BD, Redfield MM (2010) Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction. J Am Coll Cardiol 56:845–854

    PubMed Central  PubMed  Google Scholar 

  19. Borlaug BA, Redfield MM, Melenovsky V, Kane GC, Karon BL, Jacobsen SJ, Rodeheffer RJ (2013) Longitudinal changes in left ventricular stiffness: a community-based study. Circ Heart Fail 6:944–952

    PubMed  Google Scholar 

  20. Borlaug BA, Sorajja P, Nishimura RA, Lam CSP, Redfield MM (2009) Do exercise hemodynamics enhance diagnosis of heart failure with preserved ejection fraction? Circulation 120:S756

    Google Scholar 

  21. Brouwers FP, de Boer RA, van der Harst P, Voors AA, Gansevoort RT, Bakker SJ, Hillege HL, van Veldhuisen DJ, van Gilst WH (2013) Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND. Eur Heart J 34:1424–1431

    CAS  PubMed  Google Scholar 

  22. Brubaker PH, Kitzman DW (2011) Chronotropic incompetence: causes, consequences, and management. Circulation 123:1010–1020

    PubMed Central  PubMed  Google Scholar 

  23. Brubaker PH, Joo KC, Stewart KP, Fray B, Moore B, Kitzman DW (2006) Chronotropic incompetence and its contribution to exercise intolerance in older heart failure patients. J Cardiopulm Rehabil 26:86–89

    PubMed  Google Scholar 

  24. Burchfield JS, Xie M, Hill JA (2013) Pathological ventricular remodeling: mechanisms: part 1 of 2. Circulation 128:388–400

    PubMed  Google Scholar 

  25. Burke MA, Katz DH, Beussink L et al (2013) Prognostic importance of pathophysiologic markers in patients with heart failure and preserved ejection fraction. Circ Heart Fail. doi:10.1161/CIRCHEARTFAILURE.113.000854

    PubMed  Google Scholar 

  26. Burkhoff D, Mirsky I, Suga H (2005) Assessment of systolic and diastolic ventricular properties via pressure-volume analysis: a guide for clinical, translational, and basic researchers. Am J Physiol Heart Circ Physiol 289:H501–H512

    CAS  PubMed  Google Scholar 

  27. Bursi F, Weston SA, Redfield MM, Jacobsen SJ, Pakhomov S, Nkomo VT, Meverden RA, Roger VL (2006) Systolic and diastolic heart failure in the community. JAMA 296:2209–2216

    CAS  PubMed  Google Scholar 

  28. Campbell RT, Jhund PS, Castagno D, Hawkins NM, Petrie MC, McMurray JJ (2012) What have we learned about patients with heart failure and preserved ejection fraction from DIG-PEF, CHARM-preserved, and I-PRESERVE? J Am Coll Cardiol 60:2349–2356

    PubMed  Google Scholar 

  29. Choudhury L, Gheorghiade M, Bonow RO (2002) Coronary artery disease in patients with heart failure and preserved systolic function. Am J Cardiol 89:719–722

    PubMed  Google Scholar 

  30. Colin P, Ghaleh B, Hittinger L, Monnet X, Slama M, Giudicelli JF, Berdeaux A (2002) Differential effects of heart rate reduction and beta-blockade on left ventricular relaxation during exercise. Am J Physiol Heart Circ Physiol 282:H672–H679

    CAS  PubMed  Google Scholar 

  31. Dauterman K, Pak PH, Maughan WL, Nussbacher A, Ariê S, Liu CP, Kass DA (1995) Contribution of external forces to left ventricular diastolic pressure. Implications for the clinical use of the Starling law. Ann Intern Med 122:737–742

    CAS  PubMed  Google Scholar 

  32. De Keulenaer GW, Brutsaert DL (2011) Systolic and diastolic heart failure are overlapping phenotypes within the heart failure spectrum. Circulation 123:1996–2004, discussion 2005

    PubMed  Google Scholar 

  33. Deswal A, Richardson P, Bozkurt B, Mann DL (2011) Results of the Randomized Aldosterone Antagonism in Heart Failure with Preserved Ejection Fraction trial (RAAM-PEF). J Card Fail 17:634–642

    PubMed  Google Scholar 

  34. Dunlay SM, Roger VL, Weston SA, Jiang R, Redfield MM (2012) Longitudinal changes in ejection fraction in heart failure patients with preserved and reduced ejection fraction. Circ Heart Fail 5:720–726

    PubMed Central  PubMed  Google Scholar 

  35. Edelmann F, Stahrenberg R, Gelbrich G et al (2011) Contribution of comorbidities to functional impairment is higher in heart failure with preserved than with reduced ejection fraction. Clin Res Cardiol 100:755–764

    PubMed Central  PubMed  Google Scholar 

  36. Edelmann F, Wachter R, Schmidt AG et al (2013) Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial. JAMA 309:781–791

    CAS  PubMed  Google Scholar 

  37. Ennezat PV, Lefetz Y, Maréchaux S et al (2008) Left ventricular abnormal response during dynamic exercise in patients with heart failure and preserved left ventricular ejection fraction at rest. J Card Fail 14:475–480

    PubMed  Google Scholar 

  38. Flather MD, Shibata MC, Coats AJ et al (2005) Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 26:215–225

    CAS  PubMed  Google Scholar 

  39. Freiburg A, Trombitas K, Hell W et al (2000) Series of exon-skipping events in the elastic spring region of titin as the structural basis for myofibrillar elastic diversity. Circ Res 86:1114–1121

    CAS  PubMed  Google Scholar 

  40. Fukuda N, Wu Y, Nair P, Granzier HL (2005) Phosphorylation of titin modulates passive stiffness of cardiac muscle in a titin isoform-dependent manner. J Gen Physiol 125:257–271

    CAS  PubMed Central  PubMed  Google Scholar 

  41. Fukuta H, Sane DC, Brucks S, Little WC (2005) Statin therapy may be associated with lower mortality in patients with diastolic heart failure: a preliminary report. Circulation 112:357–363

    CAS  PubMed  Google Scholar 

  42. Gandhi SK, Powers JC, Nomeir AM, Fowle K, Kitzman DW, Rankin KM, Little WC (2001) The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med 344:17–22

    CAS  PubMed  Google Scholar 

  43. Gillebert TC, Leite-Moreira AF, De Hert SG (2000) Load dependent diastolic dysfunction in heart failure. Heart Fail Rev 5:345–355

    CAS  PubMed  Google Scholar 

  44. Gradman AH, Wilson JT (2009) Hypertension and diastolic heart failure. Curr Cardiol Rep 11:422–429

    PubMed  Google Scholar 

  45. Grutzner A, Garcia-Manyes S, Kotter S, Badilla CL, Fernandez JM, Linke WA (2009) Modulation of titin-based stiffness by disulfide bonding in the cardiac titin N2-B unique sequence. Biophys J 97:825–834

    PubMed Central  PubMed  Google Scholar 

  46. Guazzi M, Vicenzi M, Arena R, Guazzi MD (2011) Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study. Circulation 124:164–174

    CAS  PubMed  Google Scholar 

  47. Guo W, Schafer S, Greaser ML et al (2012) RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing. Nat Med 18:766–773

    CAS  PubMed Central  PubMed  Google Scholar 

  48. Ha JW, Chung N, Jang Y, Kang WC, Kang SM, Rim SJ, Shim WH, Cho SY, Kim SS (2000) Is the left atrial v. wave the determinant of peak pulmonary artery pressure in patients with pure mitral stenosis? Am J Cardiol 85:986–991

    CAS  PubMed  Google Scholar 

  49. Hamdani N, Krysiak J, Kreusser MM, Neef S, Dos Remedios CG, Maier LS, Kruger M, Backs J, Linke WA (2013) Crucial role for Ca2(+)/calmodulin-dependent protein kinase-II in regulating diastolic stress of normal and failing hearts via titin phosphorylation. Circ Res 112:664–674

    CAS  PubMed  Google Scholar 

  50. Hay I, Rich J, Ferber P, Burkhoff D, Maurer MS (2005) Role of impaired myocardial relaxation in the production of elevated left ventricular filling pressure. Am J Physiol Heart Circ Physiol 288:H1203–H1208

    CAS  PubMed  Google Scholar 

  51. Henkel DM, Redfield MM, Weston SA, Gerber Y, Roger VL (2008) Death in heart failure: a community perspective. Circ Heart Fail 1:91–97

    PubMed Central  PubMed  Google Scholar 

  52. Herman DS, Lam L, Taylor MR et al (2012) Truncations of titin causing dilated cardiomyopathy. N Engl J Med 366:619–628

    CAS  PubMed Central  PubMed  Google Scholar 

  53. Hidalgo CG, Chung CS, Saripalli C, Methawasin M, Hutchinson KR, Tsaprailis G, Labeit S, Mattiazzi A, Granzier HL (2013) The multifunctional Ca(2+)/calmodulin-dependent protein kinase II delta (CaMKIIdelta) phosphorylates cardiac titin’s spring elements. J Mol Cell Cardiol 54:90–97

    CAS  PubMed Central  PubMed  Google Scholar 

  54. Hidalgo C, Hudson B, Bogomolovas J, Zhu Y, Anderson B, Greaser M, Labeit S, Granzier H (2009) PKC phosphorylation of titin’s PEVK element: a novel and conserved pathway for modulating myocardial stiffness. Circ Res 105:631–638

    CAS  PubMed Central  PubMed  Google Scholar 

  55. Hoenig MR, Bianchi C, Rosenzweig A, Sellke FW (2008) The cardiac microvasculature in hypertension, cardiac hypertrophy and diastolic heart failure. Curr Vasc Pharmacol 6:292–300

    CAS  PubMed  Google Scholar 

  56. Hoit BD (2013) Left atrial size and function: role in prognosis. J Am Coll Cardiol. doi:10.1016/j.jacc.2013.10.055

    Google Scholar 

  57. Hoshijima M, Ikeda Y, Iwanaga Y et al (2002) Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery. Nat Med 8:864–871

    CAS  PubMed  Google Scholar 

  58. Hudson BD, Hidalgo CG, Gotthardt M, Granzier HL (2010) Excision of titin’s cardiac PEVK spring element abolishes PKCalpha-induced increases in myocardial stiffness. J Mol Cell Cardiol 48:972–978

    CAS  PubMed Central  PubMed  Google Scholar 

  59. Hundley WG, Kitzman DW, Morgan TM, Hamilton CA, Darty SN, Stewart KP, Herrington DM, Link KM, Little WC (2001) Cardiac cycle-dependent changes in aortic area and distensibility are reduced in older patients with isolated diastolic heart failure and correlate with exercise intolerance. J Am Coll Cardiol 38:796–802

    CAS  PubMed  Google Scholar 

  60. Ismahil MA, Hamid T, Bansal SS, Patel B, Kingery JR, Prabhu SD (2014) Remodeling of the mononuclear phagocyte network underlies chronic inflammation and disease progression in heart failure: critical importance of the cardiosplenic axis. Circ Res 114:266–282

    CAS  PubMed  Google Scholar 

  61. Iwanaga Y, Nishi I, Furuichi S, Noguchi T, Sase K, Kihara Y, Goto Y, Nonogi H (2006) B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure. J Am Coll Cardiol 47:742–748

    CAS  PubMed  Google Scholar 

  62. Jaber W, Maniu CV, Krysiak J, Shapiro BP, Meyer DM, Linke WA, Redfield MM (2008) Titin isoforms, extracellular matrix, and global chamber remodeling in experimental dilated cardiomyopathy: functional implications and mechanistic insights. Circ Heart Fail 1:192–199

    CAS  PubMed Central  PubMed  Google Scholar 

  63. Jessup M, Greenberg B, Mancini D et al (2011) Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure. Circulation 124:304–313

    CAS  PubMed  Google Scholar 

  64. Juurlink DN, Mamdani MM, Lee DS, Kopp A, Austin PC, Laupacis A, Redelmeier DA (2004) Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med 351:543–551

    CAS  PubMed  Google Scholar 

  65. Kasner M, Westermann D, Lopez B, Gaub R, Escher F, Kuhl U, Schultheiss HP, Tschope C (2011) Diastolic tissue Doppler indexes correlate with the degree of collagen expression and cross-linking in heart failure and normal ejection fraction. J Am Coll Cardiol 57:977–985

    CAS  PubMed  Google Scholar 

  66. Kawaguchi M, Hay I, Fetics B, Kass DA (2003) Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations. Circulation 107:714–720

    PubMed  Google Scholar 

  67. Kaye DM, Hoshijima M, Chien KR (2008) Reversing advanced heart failure by targeting Ca2+ cycling. Annu Rev Med 59:13–28

    CAS  PubMed  Google Scholar 

  68. Kitzman DW, Little WC, Brubaker PH, Anderson RT, Hundley WG, Marburger CT, Brosnihan B, Morgan TM, Stewart KP (2002) Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA 288:2144–2150

    PubMed  Google Scholar 

  69. Kosmala W, Holland DJ, Rojek A, Wright L, Przewlocka-Kosmala M, Marwick TH (2013) Effect of I f -channel inhibition on hemodynamic status and exercise tolerance in heart failure with preserved ejection fraction: a randomized trial. J Am Coll Cardiol 62:1330–1338

    CAS  PubMed  Google Scholar 

  70. Kramer K, Kirkman P, Kitzman D, Little WC (2000) Flash pulmonary edema: association with hypertension and reoccurrence despite coronary revascularization. Am Heart J 140:451–455

    CAS  PubMed  Google Scholar 

  71. Kranias EG, Hajjar RJ (2012) Modulation of cardiac contractility by the phospholamban/SERCA2a regulatome. Circ Res 110:1646–1660

    CAS  PubMed Central  PubMed  Google Scholar 

  72. Kruger M, Linke WA (2006) Protein kinase-A phosphorylates titin in human heart muscle and reduces myofibrillar passive tension. J Muscle Res Cell Motil 27:435–444

    PubMed  Google Scholar 

  73. Kruger M, Linke WA (2009) Titin-based mechanical signalling in normal and failing myocardium. J Mol Cell Cardiol 46:490–498

    PubMed  Google Scholar 

  74. Kruger M, Linke WA (2011) The giant protein titin: a regulatory node that integrates myocyte signaling pathways. J Biol Chem 286:9905–9912

    PubMed Central  PubMed  Google Scholar 

  75. Kruger M, Babicz K, von Frieling-Salewsky M, Linke WA (2010) Insulin signaling regulates cardiac titin properties in heart development and diabetic cardiomyopathy. J Mol Cell Cardiol 48:910–916

    PubMed  Google Scholar 

  76. Kruger M, Sachse C, Zimmermann WH, Eschenhagen T, Klede S, Linke WA (2008) Thyroid hormone regulates developmental titin isoform transitions via the PI3K/AKT pathway. Circ Res 102:439–447

    PubMed  Google Scholar 

  77. Krüger M, Kötter S, Grützner A, Lang P, Andresen C, Redfield MM, Butt E, dos Remedios CG, Linke WA (2009) Protein kinase G modulates human myocardial passive stiffness by phosphorylation of the titin springs. Circ Res 104:87–94

    PubMed  Google Scholar 

  78. Lakatta EG, Levy D (2003) Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a “set up” for vascular disease. Circulation 107:139–146

    PubMed  Google Scholar 

  79. Lakatta EG, Levy D (2003) Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease. Circulation 107:346–354

    PubMed  Google Scholar 

  80. Lam CS, Roger VL, Rodeheffer RJ, Borlaug BA, Enders FT, Redfield MM (2009) Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. J Am Coll Cardiol 53:1119–1126

    PubMed Central  PubMed  Google Scholar 

  81. Lam CS, Roger VL, Rodeheffer RJ, Bursi F, Borlaug BA, Ommen SR, Kass DA, Redfield MM (2007) Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota. Circulation 115:1982–1990

    PubMed Central  PubMed  Google Scholar 

  82. Lamas GA, Knight JD, Sweeney MO et al (2007) Impact of rate-modulated pacing on quality of life and exercise capacity—evidence from the Advanced Elements of Pacing Randomized Controlled Trial (ADEPT). Heart Rhythm 4:1125–1132

    PubMed  Google Scholar 

  83. Linke WA, Bucker S (2012) King of hearts: a splicing factor rules cardiac proteins. Nat Med 18:660–661

    CAS  PubMed  Google Scholar 

  84. Makarenko I, Opitz CA, Leake MC, Neagoe C, Kulke M, Gwathmey JK, del Monte F, Hajjar RJ, Linke WA (2004) Passive stiffness changes caused by upregulation of compliant titin isoforms in human dilated cardiomyopathy hearts. Circ Res 95:708–716

    CAS  PubMed  Google Scholar 

  85. McMurray JJ, Adamopoulos S, Anker SD et al (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 14:803–869

    CAS  PubMed  Google Scholar 

  86. Melenovsky V, Borlaug BA, Rosen B, Hay I, Ferruci L, Morell CH, Lakatta EG, Najjar SS, Kass DA (2007) Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community: the role of atrial remodeling/dysfunction. J Am Coll Cardiol 49:198–207

    PubMed  Google Scholar 

  87. Micha R, Imamura F, Wyler von Ballmoos M, Solomon DH, Hernan MA, Ridker PM, Mozaffarian D (2011) Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease. Am J Cardiol 108:1362–1370

    CAS  PubMed Central  PubMed  Google Scholar 

  88. Mohammed SF, Borlaug BA, Roger VL, Mirzoyev SA, Rodeheffer RJ, Chirinos JA, Redfield MM (2012) Comorbidity and ventricular and vascular structure and function in heart failure with preserved ejection fraction: a community based study. Circ Heart Fail 5:710–719

    PubMed Central  PubMed  Google Scholar 

  89. Nagueh SF, Shah G, Wu Y, Torre-Amione G, King NM, Lahmers S, Witt CC, Becker K, Labeit S, Granzier HL (2004) Altered titin expression, myocardial stiffness, and left ventricular function in patients with dilated cardiomyopathy. Circulation 110:155–162

    CAS  PubMed  Google Scholar 

  90. Neagoe C, Kulke M, del Monte F, Gwathmey JK, de Tombe PP, Hajjar RJ, Linke WA (2002) Titin isoform switch in ischemic human heart disease. Circulation 106:1333–1341

    PubMed  Google Scholar 

  91. Norman HS, Oujiri J, Larue SJ, Chapman CB, Margulies KB, Sweitzer NK (2011) Decreased cardiac functional reserve in heart failure with preserved systolic function. J Card Fail 17:301–308

    PubMed Central  PubMed  Google Scholar 

  92. Ommen SR, Nishimura RA, Appleton CP, Miller FA, Oh JK, Redfield MM, Tajik AJ (2000) Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation 102:1788–1794

    CAS  PubMed  Google Scholar 

  93. Owan TE, Redfield MM (2005) Epidemiology of diastolic heart failure. Prog Cardiovasc Dis 47:320–332

    PubMed  Google Scholar 

  94. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM (2006) Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355:251–259

    CAS  PubMed  Google Scholar 

  95. Packer M (2011) Can brain natriuretic peptide be used to guide the management of patients with heart failure and a preserved ejection fraction? The wrong way to identify new treatments for a nonexistent disease. Circ Heart Fail 4:538–540

    PubMed  Google Scholar 

  96. Paulus WJ, Tschope C (2013) A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 62:263–271

    PubMed  Google Scholar 

  97. Paulus WJ, Vantrimpont PJ, Shah AM (1994) Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans: assessment by bicoronary sodium nitroprusside infusion. Circulation 89:2070–2078

    CAS  PubMed  Google Scholar 

  98. Perrino C, Naga Prasad SV, Mao L, Noma T, Yan Z, Kim HS, Smithies O, Rockman HA (2006) Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction. J Clin Invest 116:1547–1560

    CAS  PubMed Central  PubMed  Google Scholar 

  99. Phan TT, Abozguia K, Nallur Shivu G et al (2009) Heart failure with preserved ejection fraction is characterized by dynamic impairment of active relaxation and contraction of the left ventricle on exercise and associated with myocardial energy deficiency. J Am Coll Cardiol 54:402–409

    PubMed  Google Scholar 

  100. Phan TT, Nallur Shivu G, Abozguia K, Davies C, Nassimizadeh M, Jimenez D, Weaver R, Ahmed I, Frenneaux M (2009) Impaired heart rate recovery and chronotropic incompetence in patients with heart failure with preserved ejection fraction. Circ Heart Fail 3:29–34

    PubMed  Google Scholar 

  101. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341:709–717

    CAS  PubMed  Google Scholar 

  102. Raskin A, Lange S, Banares K et al (2012) A novel mechanism involving four-and-a-half LIM domain protein-1 and extracellular signal-regulated kinase-2 regulates titin phosphorylation and mechanics. J Biol Chem 287:29273–29284

    CAS  PubMed Central  PubMed  Google Scholar 

  103. Redfield MM, Borlaug BA, Lewis GD et al (2012) PhosphdiesteRasE-5 Inhibition to Improve CLinical Status and EXercise Capacity in Diastolic Heart Failure (RELAX) trial: rationale and design. Circ Heart Fail 5:653–659

    PubMed Central  PubMed  Google Scholar 

  104. Redfield MM, Chen HH, Borlaug BA et al (2013) Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. JAMA 309:1268–1277

    CAS  PubMed  Google Scholar 

  105. Redfield MM, Jacobsen SJ, Burnett JCJ, Mahoney DW, Bailey KR, Rodeheffer RJ (2003) Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 289:194–202

    PubMed  Google Scholar 

  106. Reil JC, Tardif JC, Ford I, Lloyd SM, O'Meara E, Komajda M, Borer JS, Tavazzi L, Swedberg K, Böhm M (2013) Selective heart rate reduction with ivabradine unloads the left ventricle in heart failure patients. J Am Coll Cardiol 62:1977–1985

    CAS  PubMed  Google Scholar 

  107. Sakata S, Lebeche D, Sakata N et al (2007) Targeted gene transfer increases contractility and decreases oxygen cost of contractility in normal rat hearts. Am J Physiol Heart Circ Physiol 292:H2356–H2363

    CAS  PubMed  Google Scholar 

  108. Sasayama S, Nonogi H, Miyazaki S, Sakurai T, Kawai C, Eiho S, Kuwahara M (1985) Changes in diastolic properties of regional myocardium during pacing-induced ischemia in human subjects. J Am Coll Cardiol 5:599–606

    CAS  PubMed  Google Scholar 

  109. Schmidt U, del Monte F, Miyamoto MH, Matsui T, Gwathmey JK, Rosenzweig A, Hajjar RJ (2000) Restoration of diastolic function in senescent rat hearts through adenoviral gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase. Circulation 101:790–796

    CAS  PubMed  Google Scholar 

  110. Schultz JLJ, Glascock BJ, Witt SA, Nieman ML, Nattamai KJ, Liu LH, Lorenz JN, Shull GE, Kimball TR, Periasamy M (2004) Accelerated onset of heart failure in mice during pressure overload with chronically decreased SERCA2 calcium pump activity. Am J Physiol Heart Circ Physiol 286:H1146–H1153

    CAS  Google Scholar 

  111. Schwammenthal E, Vered Z, Agranat O, Kaplinsky E, Rabinowitz B, Feinberg MS (2000) Impact of atrioventricular compliance on pulmonary artery pressure in mitral stenosis: an exercise echocardiographic study. Circulation 102:2378–2384

    CAS  PubMed  Google Scholar 

  112. Schwartzenberg S, Redfield MM, From AM, Sorajja P, Nishimura RA, Borlaug BA (2012) Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy. J Am Coll Cardiol 59:442–451

    PubMed  Google Scholar 

  113. Shah RV, Desai AS, Givertz MM (2010) The effect of renin–angiotensin system inhibitors on mortality and heart failure hospitalization in patients with heart failure and preserved ejection fraction: a systematic review and meta-analysis. J Card Fail 16:260–267

    CAS  PubMed  Google Scholar 

  114. Shah SJ, Gheorghiade M (2008) Heart failure with preserved ejection fraction: treat now by treating comorbidities. JAMA 300:431–433

    CAS  PubMed  Google Scholar 

  115. Shapiro BP, Lam CS, Patel JB, Mohammed SF, Kruger M, Meyer DM, Linke WA, Redfield MM (2007) Acute and chronic ventricular-arterial coupling in systole and diastole: insights from an elderly hypertensive model. Hypertension 50:503–511

    CAS  PubMed  Google Scholar 

  116. Shiojima I, Sato K, Izumiya Y, Schiekofer S, Ito M, Liao R, Colucci WS, Walsh K (2005) Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest 115:2108–2118

    CAS  PubMed Central  PubMed  Google Scholar 

  117. Solomon SD, Janardhanan R, Verma A et al (2007) Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial. Lancet 369:2079–2087

    CAS  PubMed  Google Scholar 

  118. Solomon SD, Zile M, Pieske B et al (2012) The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial. Lancet 380:1387–1395

    CAS  PubMed  Google Scholar 

  119. Stehle R, Solzin J, Iorga B, Poggesi C (2009) Insights into the kinetics of Ca2+-regulated contraction and relaxation from myofibril studies. Pflugers Arch 458:337–357

    CAS  PubMed  Google Scholar 

  120. Steinberg BA, Zhao X, Heidenreich PA, Peterson ED, Bhatt DL, Cannon CP, Hernandez AF, Fonarow GC, Investigators GWTGSACA (2012) Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes. Circulation 126:65–75

    PubMed  Google Scholar 

  121. Taylor RS, Davies EJ, Dalal HM, Davis R, Doherty P, Cooper C, Holland DJ, Jolly K, Smart NA (2012) Effects of exercise training for heart failure with preserved ejection fraction: a systematic review and meta-analysis of comparative studies. Int J Cardiol 162:6–13

    PubMed  Google Scholar 

  122. Tedford RJ, Hassoun PM, Mathai SC et al (2012) Pulmonary capillary wedge pressure augments right ventricular pulsatile loading. Circulation 125:289–297

    PubMed Central  PubMed  Google Scholar 

  123. van Heerebeek L, Borbély A, Niessen HW, Bronzwaer JG, van der Velden J, Stienen GJ, Linke WA, Laarman GJ, Paulus WJ (2006) Myocardial structure and function differ in systolic and diastolic heart failure. Circulation 113:1966–1973

    PubMed  Google Scholar 

  124. van Heerebeek L, Hamdani N, Falcao-Pires I et al (2012) Low myocardial protein kinase G activity in heart failure with preserved ejection fraction. Circulation 126:830–839

    PubMed  Google Scholar 

  125. van Heerebeek L, Hamdani N, Handoko ML et al (2008) Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circulation 117:43–51

    PubMed  Google Scholar 

  126. Van Tassell BW, Arena R, Biondi-Zoccai G et al (2014) Effects of interleukin-1 blockade with anakinra on aerobic exercise capacity in patients with heart failure and preserved ejection fraction (from the D-HART Pilot Study). Am J Cardiol 113:321–327

    PubMed  Google Scholar 

  127. Verma A, Solomon SD (2009) Diastolic dysfunction as a link between hypertension and heart failure. Med Clin N Am 93:647–664

    CAS  PubMed  Google Scholar 

  128. Vest AR, Heneghan HM, Agarwal S, Schauer PR, Young JB (2012) Bariatric surgery and cardiovascular outcomes: a systematic review. Heart 98:1763–1777

    PubMed  Google Scholar 

  129. Westermann D, Lindner D, Kasner M et al (2011) Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction. Circ Heart Fail 4:44–52

    PubMed  Google Scholar 

  130. Yamamoto K, Burnett JCJ, Redfield MM (1997) Effect of endogenous natriuretic peptide system on ventricular and coronary function in failing heart. Am J Physiol 273:H2406–H2414

    CAS  PubMed  Google Scholar 

  131. Yancy CW, Jessup M, Bozkurt B et al (2013) 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 128:e240–e319

    PubMed  Google Scholar 

  132. Zakeri R, Borlaug BA, McNulty S et al (2013) Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study. Circ Heart Fail 7:123–130

    PubMed  Google Scholar 

  133. Zakeri R, Chamberlain AM, Roger VL, Redfield MM (2013) Temporal relationship and prognostic significance of atrial fibrillation in heart failure patients with preserved ejection fraction: a community-based study. Circulation 128:1085–1093

    PubMed  Google Scholar 

  134. Zile MR, Brutsaert DL (2002) New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment. Circulation 105:1503–1508

    PubMed  Google Scholar 

  135. Zile MR, Baicu CF, Gaasch WH (2004) Diastolic heart failure—abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med 350:1953–1959

    CAS  PubMed  Google Scholar 

  136. Zile MR, Gottdiener JS, Hetzel SJ, McMurray JJ, Komajda M, McKelvie R, Baicu CF, Massie BM, Carson PE (2011) Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction. Circulation 124:2491–2501

    PubMed  Google Scholar 

  137. Zsebo K, Yaroshinsky A, Rudy JJ, Wagner K, Greenberg B, Jessup M, Hajjar RJ (2014) Long-term effects of AAV1/SERCA2a gene transfer in patients with severe heart failure: analysis of recurrent cardiovascular events and mortality. Circ Res 114:101–108

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic, Guggenheim 9, 200 First Street, Southwest Rochester, MN, 55905, USA

    James D. Gladden & Margaret M. Redfield

  2. Department of Cardiovascular Physiology, Ruhr University Bochum, Bochum, Germany

    Wolfgang A. Linke

Authors
  1. James D. Gladden
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wolfgang A. Linke
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Margaret M. Redfield
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Margaret M. Redfield.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gladden, J.D., Linke, W.A. & Redfield, M.M. Heart failure with preserved ejection fraction. Pflugers Arch - Eur J Physiol 466, 1037–1053 (2014). https://doi.org/10.1007/s00424-014-1480-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00424-014-1480-8

Keywords

Search

Navigation